Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy of oseltamivir treatment in influenza virus-infected obese mice

mBio(2023)10.1128/mbio.00887-23Source: DataRank Database

Efficacy of oseltamivir treatment in influenza virus-infected obese mice is a research paper published in mBio (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.01)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jeremy C. Jones ORCID,Victoria Meliopoulos ORCID,Brandi Livingston,Bridgett Sharp ORCID,Leonardo D. Estrada ORCID

Live enrichment

PubMed:37341495 PMC:PMC10470499 OpenAlex:https://openalex.org/W4381469819

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: HHSN27220140006C

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: R01AI140766

National Institutes of Health

Grant: 1R01AI140766-01A1

Effects of obesity on the dynamics of Influenza transmission

American Lebanese Syrian Associated Charities

FWCI

1.01

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.00887-23

publisherhttps://doi.org/10.1128/mbio.00887-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.00887-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37341495

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10470499

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchImmune Cell Function and Interaction0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsAntiviral AgentsHumansInfluenza, HumanMice, ObeseNeuraminidaseDrug Resistance, ViralMiceInfluenza A Virus, H1N1 SubtypeOseltamivir

Keywords

OseltamivirNeuraminidase inhibitorVirusImmunologyNeuraminidaseVirologyPopulationMedicineAntiviral drugDrug resistanceImmune systemInfluenza A virusDiseaseBiologyInternal medicineInfectious disease (medical specialty)MicrobiologyCoronavirus disease 2019 (COVID-19)InterferonsObesityInfluenzaefficacyAntiviral AgentsViral DiversityMice, ObeseQR1-502MiceInfluenza A Virus, H1N1 SubtypeInfluenza, HumanDrug Resistance, ViralAnimalsHumansResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being